MedPath

Gemfibrozil

GEMFIBROZIL TABLETS USP, 600 mgRx only

Approved
Approval ID

d8ec3de8-7f83-4c29-87cb-3f3ffc2689b8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 27, 2010

Manufacturers
FDA

State of Florida DOH Central Pharmacy

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gemfibrozil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-0673
Application NumberANDA077836
Product Classification
M
Marketing Category
C73584
G
Generic Name
Gemfibrozil
Product Specifications
Route of AdministrationORAL
Effective DateAugust 27, 2010
FDA Product Classification

INGREDIENTS (10)

CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
GEMFIBROZILActive
Quantity: 600 mg in 1 1
Code: Q8X02027X3
Classification: ACTIB
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSEInactive
Code: 3NXW29V3WO
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
POLYETHYLENE GLYCOL 4000Inactive
Code: 4R4HFI6D95
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Gemfibrozil - FDA Drug Approval Details